AbbVie Inc.
DE ˙ XTRA ˙ US00287Y1091
188,50 € ↑0,35 (0,19%)
2026-06-04
AKTIENPREIS
SecurityDE:4AB / AbbVie Inc.
InstitutionWulff, Hansen & Co.
Latest Disclosed Ownership2,660 shares
Latest Disclosed Value $ 578,524
Wulff, Hansen & Co. ownership in 4AB / AbbVie Inc.

On May 7, 2026 - Wulff, Hansen & Co. filed a 13F-HR form disclosing ownership of 2,660 shares of AbbVie Inc. (DE:4AB) valued at $493,164 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 3, 2026 disclosing 2,660 shares of AbbVie Inc.. This represents a change in shares of 0.00% during the quarter. The current value of the position is $501,410 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-07 2026-03-31 13F ABBVIE COM 00287Y109 2,660 0 0.00 579 -4.78 0.5909
2026-02-03 2025-12-31 13F ABBVIE COM 00287Y109 2,660 -85 -3.10 608 -4.41 0.5099
2025-11-07 2025-09-30 13F ABBVIE COM 00287Y109 2,745 0 0.00 636 24.75 0.5471
2025-08-12 2025-06-30 13F ABBVIE COM 00287Y109 2,745 0 0.00 510 -11.48 0.4361
2025-05-14 2025-03-31 13F ABBVIE COM 00287Y109 2,745 0 0.00 575 18.07 0.5244
2025-02-11 2024-12-31 13F ABBVIE COM 00287Y109 2,745 -25 -0.90 488 -10.97 0.4615
2024-11-12 2024-09-30 13F ABBVIE COM 00287Y109 2,770 0 0.00 547 15.16 0.4955
2024-08-14 2024-06-30 13F/A-1 ABBVIE COM 00287Y109 2,770 -340 -10.93 475 -16.08 0.4691
2024-08-09 2024-06-30 13F ABBVIE COM 00287Y109 475,110 472,000 3 0.2419
2024-05-02 2024-03-31 13F ABBVIE COM 00287Y109 3,110 -45 -1.43 566 15.98 0.5655
2024-02-12 2023-12-31 13F ABBVIE COM 00287Y109 3,155 0 0.00 489 3.83 0.5428
2023-11-08 2023-09-30 13F ABBVIE COM 00287Y109 3,155 -435 -12.12 470 -2.69 0.5489
2023-08-09 2023-06-30 13F ABBVIE COM 00287Y109 3,590 -225 -5.90 484 -20.43 0.5414
2023-05-08 2023-03-31 13F ABBVIE COM 00287Y109 3,815 0 0.00 608 -1.46 0.6939
2023-02-07 2022-12-31 13F ABBVIE COM 00287Y109 3,815 -20 -0.52 617 19.61 0.7485
2022-11-04 2022-09-30 13F ABBVIE COM 00287Y109 3,835 0 0.00 515 -12.27 0.6442
2022-07-26 2022-06-30 13F ABBVIE COM 00287Y109 3,835 0 0.00 587 -5.63 0.6650
2022-05-10 2022-03-31 13F ABBVIE COM 00287Y109 3,835 -1,520 -28.38 622 -14.21 0.5922
2022-02-14 2021-12-31 13F ABBVIE COM 00287Y109 5,355 5,355 725 0.6262
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.